Anti-myeloma activity of MELK inhibitor OTS167: effects on drug-resistant myeloma cells and putative myeloma stem cell replenishment of malignant plasma cells-Reference-Cited by-同舟云学术

Anti-myeloma activity of MELK inhibitor OTS167: effects on drug-resistant myeloma cells and putative myeloma stem cell replenishment of malignant plasma cells

Published:2016-08 Issue:8 Volume:6 Page:e460-e460
ISSN:2044-5385
Container-title:Blood Cancer Journal
language:en
Short-container-title:Blood Cancer Journal

Author:

Stefka A T,Park J-H,Matsuo Y,Chung S,Nakamura Y,Jakubowiak A J,Rosebeck S

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology

Link

http://www.nature.com/articles/bcj201671.pdf

Reference15 articles.

1. Bianchi G, Anderson KC . Understanding biology to tackle the disease: Multiple myeloma from bench to bedside, and back. CA Cancer J Clin 2014; 64: 422–444.

2. Matsui W, Wang Q, Barber JP, Brennan S, Smith BD, Borrello I et al. Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance. Cancer Res 2008; 68: 190–197.

3. Ganguly R, Mohyeldin A, Thiel J, Kornblum HI, Beullens M, Nakano I . MELK-a conserved kinase: functions, signaling, cancer, and controversy. Clin Transl Med 2015; 4: 11.

4. Zhan F, Barlogie B, Arzoumanian V, Huang Y, Williams DR, Hollmig K et al. Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosis. Blood 2007; 109: 1692–1700.

5. Zhan F, Huang Y, Colla S, Stewart JP, Hanamura I, Gupta S et al. The molecular classification of multiple myeloma. Blood 2006; 108: 2020–2028.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Maternal embryonic leucine zipper kinase in tumor cells and tumor microenvironment: An emerging player and promising therapeutic opportunity;Cancer Letters;2023-04

2. MELK Inhibition Effectively Suppresses Growth of Glioblastoma and Cancer Stem-Like Cells by Blocking AKT and FOXM1 Pathways;Frontiers in Oncology;2021-01-14

3. Enigmatic MELK: The controversy surrounding its complex role in cancer;Journal of Biological Chemistry;2020-06

Phillygenin, a MELK Inhibitor, Inhibits Cell Survival and Epithelial–Mesenchymal Transition in Pancreatic Cancer Cells

;OncoTargets and Therapy;2020-04

5. Mutant P53 induces MELK expression by release of wild-type P53-dependent suppression of FOXM1;npj Breast Cancer;2020-01-03